Fishman Corey N. - Net Worth and Insider Trading
Fishman Corey N. Net Worth
The estimated net worth of Fishman Corey N. is at least $68,067 dollars as of 2024-11-05. Fishman Corey N. is the CEO of Iterum Therapeutics PLC and owns about 54,449 shares of Iterum Therapeutics PLC (ITRM) stock worth over $68,067. Details can be seen in Fishman Corey N.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fishman Corey N. has not made any transactions after 2023-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Fishman Corey N.
Fishman Corey N. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fishman Corey N. owns 3 companies in total, including BioSpecifics Technologies Corp (BSTC) , Momenta Pharmaceuticals Inc (MNTA) , and Iterum Therapeutics PLC (ITRM) .
Click here to see the complete history of Fishman Corey N.’s form 4 insider trades.
Insider Ownership Summary of Fishman Corey N.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BSTC | BioSpecifics Technologies Corp | 2020-05-01 | director |
| MNTA | Momenta Pharmaceuticals Inc | 2019-06-19 | director |
| ITRM | Iterum Therapeutics PLC | 2023-11-20 | director & President & CEO |
Fishman Corey N. Latest Holdings Summary
Fishman Corey N. currently owns a total of 1 stock. Fishman Corey N. owns 54,449 shares of Iterum Therapeutics PLC (ITRM) as of November 20, 2023, with a value of $68,067.
Latest Holdings of Fishman Corey N.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITRM | Iterum Therapeutics PLC | 2023-11-20 | 54,449 | 1.25 | 68,067 |
Holding Weightings of Fishman Corey N.
Fishman Corey N. Form 4 Trading Tracker
According to the SEC Form 4 filings, Fishman Corey N. has made a total of 2 transactions in Iterum Therapeutics PLC (ITRM) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Iterum Therapeutics PLC is the acquisition of 10,000 shares on November 20, 2023, which cost Fishman Corey N. around $15,900.
Insider Trading History of Fishman Corey N.
- 1
Fishman Corey N. Trading Performance
GuruFocus tracks the stock performance after each of Fishman Corey N.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fishman Corey N. is -14.3%. GuruFocus also compares Fishman Corey N.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Fishman Corey N. within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Fishman Corey N.'s insider trading performs compared to the benchmark.
Performance of Fishman Corey N.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.37 | | | | | |
| Relative Return to S&P 500(%) | 0.88 | | | | | |
Fishman Corey N. Ownership Network
Ownership Network List of Fishman Corey N.
Ownership Network Relation of Fishman Corey N.
Fishman Corey N. Owned Company Details
What does BioSpecifics Technologies Corp do?
Who are the key executives at BioSpecifics Technologies Corp?
Fishman Corey N. is the director of BioSpecifics Technologies Corp. Other key executives at BioSpecifics Technologies Corp include director & 10 percent owner Toby Wegman , director & Chief Executive Officer Joseph Truitt , and Chief Financial Officer Patrick Hutchison .
BioSpecifics Technologies Corp (BSTC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of BioSpecifics Technologies Corp (BSTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioSpecifics Technologies Corp (BSTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
BioSpecifics Technologies Corp (BSTC)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioSpecifics Technologies Corp Insider Transactions
Fishman Corey N. Mailing Address
Above is the net worth, insider trading, and ownership report for Fishman Corey N.. You might contact Fishman Corey N. via mailing address: Durata Therapeutics, Inc., 89 Headquarters Plaza North, 14th Floor, Morristown Nj 07960.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
